WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WUXI, China, June 20, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it planned to expand the new...

from PR Newswire: https://prn.to/2x2Ix0X